0000827871-16-000081.txt : 20161123 0000827871-16-000081.hdr.sgml : 20161123 20161123160054 ACCESSION NUMBER: 0000827871-16-000081 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161123 DATE AS OF CHANGE: 20161123 EFFECTIVENESS DATE: 20161123 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EAGLE PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000827871 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-275107 FILM NUMBER: 162016577 BUSINESS ADDRESS: STREET 1: 50 TICE BOULEVARD, SUITE 315 CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 BUSINESS PHONE: 201-326-5300 MAIL ADDRESS: STREET 1: 50 TICE BOULEVARD, SUITE 315 CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 FORMER COMPANY: FORMER CONFORMED NAME: EAGLE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19880120 D 1 primary_doc.xml X0707 D LIVE 0000827871 EAGLE PHARMACEUTICALS, INC. 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ NEW JERSEY 07677 201-326-5300 DELAWARE EAGLE PHARMACEUTICALS INC Corporation true Scott Tarriff C/O EAGLE PHARMACEUTICALS, INC. 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ NEW JERSEY 07677 Executive Officer Director Steven L. Krill C/O EAGLE PHARMACEUTICALS, INC. 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ NEW JERSEY 07677 Executive Officer David E. Riggs C/O EAGLE PHARMACEUTICALS, INC. 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ NEW JERSEY 07677 Executive Officer Adrian Hepner C/O EAGLE PHARMACEUTICALS, INC. 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ NEW JERSEY 07677 Executive Officer Michael Graves C/O EAGLE PHARMACEUTICALS, INC. 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ NEW JERSEY 07677 Director Steven Ratoff C/O EAGLE PHARMACEUTICALS, INC. 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ NEW JERSEY 07677 Director Sander Flaum C/O EAGLE PHARMACEUTICALS, INC. 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ NEW JERSEY 07677 Director David Pernock C/O EAGLE PHARMACEUTICALS, INC. 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ NEW JERSEY 07677 Director Douglas L. Braunstein C/O EAGLE PHARMACEUTICALS, INC. 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ NEW JERSEY 07677 Director Robert L. Glenning C/O EAGLE PHARMACEUTICALS, INC. 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ NEW JERSEY 07677 Director Pharmaceuticals Decline to Disclose 06b false 2016-11-16 true true true Acquisition 0 50740728 2740728 48000000 Total offering amount includes $48,000,000 of milestone payments. Such payments shall be made only if certain milestones are met. The seller may elect to receive milestone payments in stock or cash. false 2 0 0 0 false EAGLE PHARMACEUTICALS, INC. /s/ John W. LaRocca John W. LaRocca EVP and General Counsel 2016-11-23